Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Patrick Arveux"'
Autor:
Julien Simon, Tienhan Sandrine Dabakuyo-Yonli, Patrick Arveux, Sylvain Ladoire, Oumar Billa, Charles Coutant, Marie Chaix, Patrick Roignot, Catherine Quantin, Ariane Mamguem Kamga
Publikováno v:
British Journal of Cancer
Background According to international guidelines, endocrine therapy (ET) is the preferred option for hormone receptor-positive (HR+) HER2-negative (HER2−) metastatic breast cancer. In spite of clear recommendations, these are not strictly followed
Autor:
Michel Velten, Gaëtane Simon, Frédérique Penault-Llorca, Anthony Gonçalves, Marion Bertho, Jean-Marc Ferrero, Marianne Leheurteur, Michaël Chevrot, Florence Dalenc, Roman Rouzier, Anne Jaffre, Marie-Paule Lebitasy, Véronique D'Hondt, Suzette Delaloge, Anne Patsouris, Lionel Uwer, Patrick Arveux, Christelle Levy, David Pérol, Jean-Sebastien Frenel, Jean-Christophe Eymard, Mathias Breton, Julien Fraisse, Paul Cottu
Publikováno v:
Cancer Research. 80:P2-19
Background: Bone-only (BO) metastatic breast cancer (MBC), defined as bone as unique site of metastasis at MBC diagnosis, is thought to carry a better prognosis among MBC. However, only small retrospective series and data from selected randomized con
Autor:
Charles Coutant, Sylvie Giacchetti, Patrick Soulié, Sophie Guillermet, Oumar Billa, S. Delaloge, F Andre, Olivia Dialla, Sarah Dauchy, Sibille Everhard, Mario Campone, Carole Tarpin, Charles Cecile, Patrick Arveux, Anne-Laure Martin, Jean-Marc Ferrero, Cédric Lemogne, Florence Joly, Marie-Ange Mouret-Reynier, Florence Lerebours, Sandrine Dabakuyo Yonli
Publikováno v:
Cancer Research. 80:P6-11
Background: The incidence of breast cancer (BC) increases with age. However, there appears to be a trend that elderly patients with BC receive less than the standard treatment compared to younger ones and this leads to poorer outcomes. The aim of thi
Autor:
Jonathan Cottenet, Patrick Arveux, Catherine Quantin, Pascale Tubert-Bitter, Philippe Bonniaud, Alain Bernard, Lionel Piroth
Publikováno v:
Cancers
Cancers, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Volume 13
Issue 6
Cancers, MDPI, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Cancers, Vol 13, Iss 1436, p 1436 (2021)
Cancers, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Volume 13
Issue 6
Cancers, MDPI, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Cancers, Vol 13, Iss 1436, p 1436 (2021)
(1) Background: Several smaller studies have shown that COVID-19 patients with cancer are at a significantly higher risk of death. Our objective was to compare patients hospitalized for COVID-19 with cancer to those without cancer using national data
Autor:
Patrick Arveux, Julien Simon, Catherine Quantin, Sonia Bechraoui-Quantin, Karine Goueslard, Jean-Michel Petit
Publikováno v:
Cancers, Vol 13, Iss 308, p 308 (2021)
Cancers
Volume 13
Issue 2
Cancers
Volume 13
Issue 2
The aim of this large retrospective cohort study was to use a quasi-exhaustive national medico-administrative database of deliveries in France to determine the risk of developing pancreatic cancer (PC) in women with a history of gestational diabetes
Autor:
Olivier Tredan, Johan Adnet, Fabrice Andre, Paul Cottu, Ines Vaz-Luis, Christel Mesleard, Sarah Dauchy, Patrick Arveux, Christelle Levy, Marina Rousseau Tsangaris, Anne Laure Martin, Agnès Dumas
Publikováno v:
ESMO Open
ESMO Open, Vol 4, Iss 5 (2019)
ESMO Open, Vol 4, Iss 5 (2019)
Background Corresponding with improved survival among patients with breast cancer, the awareness of the long-term effects of cancer treatments has increased. CANcer TOxicities (CANTO) aims to identify predictors of development and persistence of long
Autor:
Monica Neri, Émilie Cordina Duverger, Corinne Charlier, Marc-André Verner, Sami Haddad, Pascal Guénel, Delphine Bachelet, Patrick Arveux
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 16
Issue 2
International Journal of Environmental Research and Public Health, Vol 16, Iss 2, p 271 (2019)
Volume 16
Issue 2
International Journal of Environmental Research and Public Health, Vol 16, Iss 2, p 271 (2019)
Exposure to environmental chemicals with hormonal effects, such as organochlorine compounds (OCs), during developmental periods of breast cells may have an impact on the incidence of breast cancer later in life. However, the assessment of exposure to
Autor:
G. Gatta, A. Trama, R. Capocaccia, Monika Hackl, Elizabeth Van Eycken, Kris Henau, Nadya Dimitrova, Mario Sekerija, Ladislav Dušek, Margit Mägi, Nea Malila, Maarit Leinonen, Michel Velten, Xavier Troussard, Veronique Bouvier, Anne-Valérie Guizard, Anne-Marie Bouvier, Patrick Arveux, Marc Maynadié, Anne-Sophie Woronoff, Michel Robaszkiewicz, Isabelle Baldi, Alain Monnereau, Brigitte Tretarre, Marc Colonna, Florence Molinié, Simona Bara, Claire Schvartz, Bénédicte Lapôtre-Ledoux, Pascale Grosclaude, Roland Stabenow, Sabine Luttmann, Alice Nennecke, Jutta Engel, Gabriele Schubert-Fritschle, Jan Heidrich, Bernd Holleczek, Jón Gunnlaugur Jónasson, Kerri Clough-Gorr, Harry Comber, Guido Mazzoleni, Adriano Giacomin, Antonella Sutera Sardo, Alessandro Barchielli, Diego Serraino, Roberta De Angelis, Sandra Mallone, Andrea Tavilla, Daniela Pierannunzio, Silvia Rossi, Mariano Santaquilani, Arnold Knijn, Fabio Pannozzo, Valerio Gennaro, Lucia Benfatto, Paolo Ricci, Mariangela Autelitano, Gianbattista Spagnoli, Mario Fusco, Mario Usala, Francesco Vitale, Maria Michiara, Rosario Tumino, Lucia Mangone, Fabio Falcini, Stefano Ferretti, Rosa Angela Filiberti, Enza Marani, Arturo Iannelli, Flavio Sensi, Silvano Piffer, Maria Gentilini, Anselmo Madeddu, Antonio Ziino, Sergio Maspero, Pina Candela, Fabrizio Stracci, Giovanna Tagliabue, Massimo Rugge, Annalisa Trama, Gemma Gatta, Laura Botta, Riccardo Capocaccia, Santa Pildava, Giedre Smailyte, Neville Calleja, Tom Børge Johannesen, Jadwiga Rachtan, Stanisław Góźdź, Jerzy Błaszczyk, Kamila Kępska, Forjaz de Lacerda, Maria José Bento, Ana Miranda, Chakameh Safaei Diba, Enrique Almar, Nerea Larrañaga, Arantza Lopez de Munain, Ana Torrella-Ramos, José María Díaz García, Rafael Marcos-Gragera, Maria Josè Sanchez, Carmen Navarro, Diego Salmeron, Conchi Moreno-Iribas, Jaume Galceran, Marià Carulla, Mohsen Mousavi, Christine Bouchardy, Silvia M. Ess, Andrea Bordoni, Isabelle Konzelmann, Jem Rashbass, Anna Gavin, David H. Brewster, Dyfed Wyn Huws, Otto Visser, Magdalena Bielska-Lasota, Maja Primic-Zakelj, Ian Kunkler, Ellen Benhamou
Rare cancers epidemiology is better known compared to the other rare diseases. Thanks to the long history of the European population-based cancer registries and to the EUROCARE huge database, the burden of rare cancers has been estimated the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5139fe28ffab91e999f7087ec9b88a15
http://hdl.handle.net/11392/2380545
http://hdl.handle.net/11392/2380545
Autor:
Pasquali, Sandro, Bonvalot, Sylvie, Tzanis, Dimitri, Casali Paolo, G., Trama, Annalisa, Gronchi, Alessandro, Rarecarenet, Wg, Monika, Hackl, Elizabeth, Van Eycken, Kris, Henau, Nadya, Dimitrova, Mario, Sekerija, Ladislav, Dušek, Margit, Mägi, Nea, Malila, Maarit, Leinonen, Michel, Velten, Xavier, Troussard, Veronique, Bouvier, Anne-Valérie, Guizard, Anne-Marie, Bouvier, Patrick, Arveux, Marc, Maynadié, Anne-Sophie, Woronoff, Michel, Robaszkiewicz, Isabelle, Baldi, Alain, Monnereau, Brigitte, Tretarre, Marc, Colonna, Florence, Molinié, Simona, Bara, Claire, Schvartz, Bénédict, e Lapôtre-Ledoux, Pascale, Grosclaude, Roland, Stabenow, Sabine, Luttmann, Alice, Nennecke, Jutta, Engel, Gabriele, Schubert-Fritschle, Jan, Heidrich, Bernd, Holleczek, Jón, Gunnlaugur Jónasson, Kerri, Clough-Gorr, Harry, Comber, Guido, Mazzoleni, Adriano, Giacomin, Antonella, Sutera Sardo, Alessandro, Barchielli, Diego, Serraino, Roberta, De Angelis, Sandra, Mallone, Andrea, Tavilla, Daniela, Pierannunzio, Silvia, Rossi, Mariano, Santaquilani, Arnold, Knijn, Fabio, Pannozzo, Valerio, Gennaro, Lucia, Benfatto, Paolo, Ricci, Mariangela, Autelitano, Gianbattista, Spagnoli, Mario, Fusco, Mario, Usala, Francesco, Vitale, Maria, Michiara, Rosario, Tumino, Lucia, Mangone, Fabio, Falcini, Ferretti, Stefano, Rosa Angela, Filiberti, Enza, Marani, Arturo, Iannelli, Flavio, Sensi, Silvano, Piffer, Maria, Gentilini, Anselmo, Madeddu, Antonio, Ziino, Sergio, Maspero, Pina, Candela, Fabrizio, Stracci, Giovanna, Tagliabue, Massimo, Rugge, Annalisa, Trama, Gemma, Gatta, Laura, Botta, Riccardo, Capocaccia, Santa, Pildava, Giedre, Smailyte, Neville, Calleja, Tom, Børge Johannesen, Jadwiga, Rachtan, Stanisław, Góźdź, Jerzy, Błaszczyk, Kamila, Kępska, Gonçalo, Forjaz de Lacerda, Maria José, Bento, Ana, Miranda, Chakameh, Safaei Diba, Enrique, Almar, Nere, a Larrañaga, Arantza, Lopez de Munain, Ana, Torrella-Ramos, José Marí, a Díaz García, Rafael, Marcos-Gragera, Maria Josè, Sanchez, Carmen, Navarro, Diego, Salmeron, Conchi, Moreno-Iribas, Jaume, Galceran, Marià, Carulla, Mohsen, Mousavi, Christine, Bouchardy, Silvia M., Ess, Andrea, Bordoni, Isabelle, Konzelmann, Jem, Rashbass, Ann, a Gavin, David H., Brewster, Dyfed, Wyn Huws, Otto, Visser, Magdalena, Bielska-Lasota, Maja, Primic-Zakelj, Ian, Kunkler, Ellen, Benhamou
Patients with soft tissue sarcoma (STS) experienced better outcomes when treated according to existing clinical practice guidelines either at reference institution or dedicated treatment networks. Despite increasing evidence supporting referral to sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d66d6a7514c04912241980f78e02863
http://hdl.handle.net/10447/401662
http://hdl.handle.net/10447/401662
Autor:
German Cano-Sancho, Francesca Mancini, Gianluca Severi, Patrick Arveux, Juliette Gambaretti, Philippe Marchand, Jean-Philippe Antignac, Marina Kvaskoff, Marie-Christine Boutron-Ruault
Publikováno v:
International Journal of Cancer
International Journal of Cancer, Wiley, 2019, ⟨10.1002/ijc.32357⟩
International Journal of Cancer, Wiley, 2019, 146 (4), pp.917-928. ⟨10.1002/ijc.32357⟩
International Journal of Cancer, Wiley, 2019, ⟨10.1002/ijc.32357⟩
International Journal of Cancer, Wiley, 2019, 146 (4), pp.917-928. ⟨10.1002/ijc.32357⟩
International audience; Endocrine-disrupting chemicals are proposed to increase breast cancer (BC) incidence. Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), two perfluorinated alkylated substances (PFASs), are suspected to be ubi